English | Español

Regulatory
+ Regulatory
Patient Daily | Feb 11, 2026

Riley Gaines on 340B: It 'was meant to help vulnerable patients, but it’s being abused by hospitals'
+ Pharmaceuticals
Patient Daily | Feb 11, 2026

Penn Medicine study links cholesterol crystals to early changes in fatty liver disease
+ Pharmaceuticals
Patient Daily | Feb 11, 2026

Neil G. Bluhm donates $50 million to advance heart care at Northwestern Medicine
+ Pharmaceuticals
Patient Daily | Feb 11, 2026

Clinical trial begins on nasal spray aiming to prevent common respiratory illnesses
+ Pharmaceuticals
Patient Daily | Feb 11, 2026

Vanderbilt researchers identify new cellular mechanism connected to healthy aging
+ Pharmaceuticals
Patient Daily | Feb 11, 2026

Texas A&M researchers identify novel RNA linked to blood cancer severity
+ Pharmaceuticals
Patient Daily | Feb 11, 2026

Study finds significant gap between medicaid enrollment and actual patient care
+ Pharmaceuticals
Patient Daily | Feb 11, 2026

Targeted therapy improves movement in less impaired arms after stroke

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones